Patient-specific 3D microfluidic tissue model for multiple myeloma

Tissue Engineering - Part C: Methods

Volumn 20, Issue 8, 2014, Pages 663-670

  Zhang, Wenting ^a   Lee, Woo Y ^a   Siegel, David S ^b   Tolias, Peter ^a   Zilberberg, Jenny ^b  

^a Stevens Institute of Technology   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL CULTURE; EXPANSION; MICROFLUIDICS; TISSUE;

3-D MICROFLUIDIC; BONE MARROW CELLS; BONE MARROW MICROENVIRONMENT; MICROFLUIDIC PLATFORMS; MONONUCLEAR CELLS; MULTIPLE MYELOMA; PATIENT SPECIFIC; REAL TIME MONITORING;

CELLS;

CD38 ANTIGEN; CD56 ANTIGEN; SYNDECAN 1; TISSUE SCAFFOLD;

ARTICLE; BONE MARROW CELL; CELL EXPANSION; CELL INTERACTION; CELL LINE; CELL PROLIFERATION; COCULTURE; CONFOCAL LASER MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROFLUIDICS; MONONUCLEAR CELL; MULTIPLE MYELOMA; MYELOMA CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; BIOLOGICAL MODEL; CLINICAL TRIAL; DEVICES; METABOLISM; MICROFLUIDIC ANALYSIS; PATHOLOGY; PERSONALIZED MEDICINE; PROCEDURES; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT;

BONE MARROW CELLS; COCULTURE TECHNIQUES; HUMANS; INDIVIDUALIZED MEDICINE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; OSTEOBLASTS; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84905179282     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2013.0490     Document Type: Article

References (17)

1. Rajkumar, S.V. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88, 226, 2013.
2. Neri, P., and Bahlis, N.J. Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma. Curr Cancer Drug Targets 12, 776, 2012.
3. Roodman, G.D. Osteoblast function in myeloma. Bone 48, 135, 2011.
4. Roodman, G.D. Targeting the bone microenvironment in multiple myeloma. J Bone Miner Metab 28, 244, 2010.
5. Yaccoby, S., and Epstein, J. The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood 94, 3576, 1999.
6. Yaccoby, S., Barlogie, B., and Epstein, J. Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood 92, 2908, 1998.
7. Kirshner, J., Thulien, K.J., Martin, L.D., Debes Marun, C., Reiman, T., Belch, A.R., et al. A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood 112, 2935, 2008.
8. Lee, J.H., Gu, Y., Wang, H., and Lee, W.Y. Microfluidic 3D bone tissue model for high-throughput evaluation of wound-healing and infection-preventing biomaterials. Biomaterials 33, 999, 2012.
9. Lee, J.H., Wang, H., Kaplan, J.B., and Lee, W.Y. Microfluidic approach to create three-dimensional tissue models for biofilm-related infection of orthopaedic implants. Tissue Eng Part C Methods 17, 39, 2010.
10. Lee, J.H., Kaplan, J.B., and Lee, W.Y. Microfluidic devices for studying growth and detachment of Staphylococcus epidermidis biofilms. Biomed Microdevices 10, 489, 2008.
11. Wells, A.D., Gudmundsdottir, H., and Turka, L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100, 3173, 1997.
12. Groen, R.W., de Rooij, M.F., Kocemba, K.A., Reijmers, R.M., de Haan-Kramer, A., Overdijk, M.B., et al. Ncadherin- mediated interaction with multiple myeloma cells inhibits osteoblast differentiation. Haematologica 96, 1653, 2011.
13. Damiano, J.S., Cress, A.E., Hazlehurst, L.A., Shtil, A.A., and Dalton, W.S. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93, 1658, 1999.
14. Zlei, M., Egert, S., Wider, D., Ihorst, G., Wasch, R., and Engelhardt, M. Characterization of in vitro growth of multiple myeloma cells. Exp Hematol 35, 1550, 2007.
15. Calimeri, T., Battista, E., Conforti, F., Neri, P., Di Martino, M.T., Rossi, M., et al. A unique three-dimensional SCIDpolymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells. Leukemia 25, 707, 2011.
16. Yata, K., and Yaccoby, S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia 18, 1891, 2004.
17. Yaccoby, S., Johnson, C.L., Mahaffey, S.C., Wezeman, M.J., Barlogie, B., and Epstein, J. Antimyeloma efficacy of thalidomide in the SCID-hu model. Blood 100, 4162, 2002.